The New Horizon Fellowship Committee is very pleased to announce the launch of the New Horizon Fellowship in rheumatism and musculoskeletal diseases to Young Research Fellows (formerly known as ARTICULUM fellowship, it has supported around 60 fellows over the past 15 years).

The purpose of the fellowship is to provide opportunities for young scientists from any country with an interest in rheumatism and musculoskeletal diseases to conduct a research project. As stated before, these research projects should be undertaken at the facility of an european EULAR Center of Excellence.

The Fellowships will provide funding of up to €15,000 to support a Fellow to undertake a research project for up to 6 months. Funding is primarily intended for salary support. Individuals will be selected to receive the New Horizon Fellowship. Applications will be evaluated by the New Horizon Fellowship Committee, which is composed of internationally renown research experts in the fields of rheumatism and musculoskeletal diseases.

New Horizon is an educational initiative comprising a network of European physicians and centres of excellence in rheumatology, whose aim is to “Promote excellence in information exchange, education, training and disease management in rheumatism and musculoskeletal diseases.” 

The New Horizon Fellowship is a non-profit project, with financial support from Eli Lilly.